跳至主要内容
临床试验/NCT06050590
NCT06050590Unknown不适用

Impact of Peripheral Sensory Stimulation of the Hand and Synchronized Deep Breathing in the Treatment of Post-Traumatic Stress Disorder: Assessing Safety and Effectiveness

NeuroGlove LLC2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2023年8月14日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
6
试验地点
2
主要终点
Portion of participants with adverse events

研究概览

简要总结

This is a prospective, home-based, interventional clinical study in which 6 subjects will be enrolled. Six (6) subjects who suffer from post-traumatic stress disorder will receive treatment using the NeuroGlove.

详细描述

This is a prospective, home-based, interventional clinical study in which 6 subjects will be enrolled. Six (6) subjects who suffer from post-traumatic stress disorder will receive treatment using the NeuroGlove.

There will be a single cohort in the study consisting of the subjects with PTSD who will receive treatment with NeuroGlove.

The trial is intended to evaluate the impact of the device use on active PTSD symptoms and subject sense of well-being.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
  • Men and women ≥18 and <85 years of age.
  • Carry an active diagnosis of PTSD.
  • Suffer from PTSD symptoms that impact subject's daily activities and quality of life.

排除标准

  • Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
  • Subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
  • Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)

结局指标

主要结局

Portion of participants with adverse events

时间窗: 4 weeks

Rate and severity of adverse events related to the use of the NeuroGlove.

PTSD Symptom Reduction

时间窗: 4 weeks

Change in PTSD symptoms and subject's sense of well-being

次要结局

  • PTSD Symptom Severity(4 weeks)

研究者

发起方
NeuroGlove LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验